Genetic basis of endocrine disease 3: Molecular defects in thyroid gland neoplasia.

Suppr

超能文献

作者信息

Fagin J A

机构信息

Division of Endocrinology, Cedars-Sinai Medical Center, University of California School of Medicine, Los Angeles 90048.

出版信息

J Clin Endocrinol Metab. 1992 Dec;75(6):1398-400. doi: 10.1210/jcem.75.6.1464638.

DOI:10.1210/jcem.75.6.1464638

PMID:1464638

Abstract

摘要

相似文献

Genetic basis of endocrine disease 3: Molecular defects in thyroid gland neoplasia.

J Clin Endocrinol Metab. 1992 Dec;75(6):1398-400. doi: 10.1210/jcem.75.6.1464638.

Genetic basis of endocrine disease 5. Molecular genetics of parathyroid gland neoplasia.

J Clin Endocrinol Metab. 1993 Nov;77(5):1108-12. doi: 10.1210/jcem.77.5.8077300.

Genetic alterations in human epithelial thyroid tumours.

Clin Endocrinol (Oxf). 1998 May;48(5):531-46. doi: 10.1046/j.1365-2265.1998.00443.x.

[Update on differenciated thyroid carcinoma].

Bull Cancer. 2002 Jan;89(1):113-23.

Activating mutations of the TSH receptor in differentiated thyroid carcinomas.

Oncogene. 1995 Nov 2;11(9):1907-11.

Granular-cell pituicytoma associated with multiple endocrine neoplasia type.

J Neurosurg. 1982 Apr;56(4):594-6. doi: 10.3171/jns.1982.56.4.0594.

[Abnormality of hormonal response in human thyroid carcinoma--molecular aspect].

Rinsho Byori. 1988 Dec;36(12):1358-63.

Pattern of ras and gsp oncogene mutations in radiation-associated human thyroid tumors.

Oncogene. 1995 Aug 3;11(3):601-3.

[Molecular basis of tumors arising in thyroid follicular cells].

Ann Chir. 1999;53(3):237-43.

Deletion of genes on chromosome 1 in endocrine neoplasia.

Nature. 1987;328(6130):524-6. doi: 10.1038/328524a0.

引用本文的文献

Endobiogeny: a global approach to systems biology (part 1 of 2).

Glob Adv Health Med. 2013 Jan;2(1):64-78. doi: 10.7453/gahmj.2013.2.1.011.

Evolving approaches to patients with advanced differentiated thyroid cancer.

Endocr Rev. 2013 Jun;34(3):439-55. doi: 10.1210/er.2012-1038. Epub 2013 Apr 10.

Proteomic profiling of thyroid papillary carcinoma.

J Thyroid Res. 2012;2012:815079. doi: 10.1155/2012/815079. Epub 2012 Feb 12.

Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue.

Mol Carcinog. 2006 Aug;45(8):613-26. doi: 10.1002/mc.20193.

Immunohistochemical Localization of p53 in Human Thyroid Neoplasms: Correlation with Biological Behavior.

Endocr Pathol. 1997 Spring;8(1):21-28. doi: 10.1007/BF02739704.

CD26 (Dipeptidyl Aminopeptidase IV) Expression in Normal and Diseased Human Thyroid Glands.

Endocr Pathol. 1998 Spring;9(1):43-52. doi: 10.1007/BF02739951.

Expression patterns of cellular growth-controlling genes in non-medullary thyroid cancer: basic aspects.

Rev Endocr Metab Disord. 2000 Apr;1(3):183-96. doi: 10.1023/a:1010079031162.

Fra-1 expression in malignant and benign thyroid tumor.

Korean J Intern Med. 2001 Jun;16(2):93-7. doi: 10.3904/kjim.2001.16.2.93.

Expression of sodium iodide symporter in benign and malignant human thyroid tissues.

Endocr Pathol. 2001 Spring;12(1):15-21. doi: 10.1385/ep:12:1:15.

Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis.

Am J Pathol. 2001 Mar;158(3):987-96. doi: 10.1016/s0002-9440(10)64045-x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验